12/20/2018 /
Apply to receive up to $5,000 toward your education and becoming an agent of change in the epilepsy community.
12/19/2018 /
Death certification in status epilepticus is likely to be an underestimate of the reality. Further efforts are urgently needed to determine the extent of status epilepticus-related deaths and all deaths in patients with epilepsy.
12/18/2018 /
The trial achieved its primary endpoint of safety and tolerability and showed OV935 was generally well tolerated.
12/14/2018 /
A round-up of the top epilepsy research news from the past month.
12/14/2018 /
RogCon and The Florey Institute of Neuroscience presented preclinical data on the company’s lead program, RC-222, an antisense oligonucleotide designed to down-regulate SCN2A.
12/14/2018 /
A retrospective study evaluating continuous electroencephalography (cEEG) of children in intensive care units (ICUs) found a higher than anticipated number of seizures.
12/13/2018 /
Three FDA-approved drugs designed to treat other conditions significantly reduced seizure-like movement in zebrafish.
12/11/2018 /
Discover the latest about what’s happening at CURE and in our community in the December 2018 CURE Update from Chief Scientific Officer, Laura Lubbers!
12/10/2018 /
Study finds the Refractory Epilepsy Screening Tool for LGS may be a valuable clinical tool in identifying patients requiring further diagnostic evaluation for LGS.
